Literature DB >> 20372065

Reduced mortality and moderate alcohol consumption: the phospholipase D-mTOR connection.

David A Foster1.   

Abstract

Many studies have suggested that moderate alcohol consumption reduces mortality. There is also substantial evidence that lifespan is extended with suppression of TOR (target of rapamycin). It was reported recently that rapamycin is able to extend the lifespan of a mammal--implicating the mammalian TOR (mTOR). mTOR has a requirement for the lipid second messenger phosphatidic acid (PA), which is generated by phospholipase D (PLD). Therefore, in principle, suppression of PLD would be similar to treatment with rapamycin. Significantly, PLD utilizes ethanol preferentially over water in the hydrolysis reaction that ordinarily generates PA. In the presence of ethanol, phosphatidyl-ethanol is generated at the expense of PA leading to the suppression of mTOR. This reaction, known as the transphosphatidylation reaction, provides a mechanistic basis for the reduced mortality observed with moderate consumption of alcohol--that being the suppression of mTOR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372065      PMCID: PMC2957519          DOI: 10.4161/cc.9.7.11145

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China.

Authors:  J M Yuan; R K Ross; Y T Gao; B E Henderson; M C Yu
Journal:  BMJ       Date:  1997-01-04

Review 2.  Therapeutic potential of target of rapamycin inhibitors.

Authors:  John B Easton; Peter J Houghton
Journal:  Expert Opin Ther Targets       Date:  2004-12       Impact factor: 6.902

3.  Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction.

Authors:  Patrick R Hagner; Krystyna Mazan-Mamczarz; Bojie Dai; Sharon Corl; X Frank Zhao; Ronald B Gartenhaus
Journal:  Blood       Date:  2009-03-17       Impact factor: 22.113

4.  Acute alcohol intoxication enhances myocardial eIF4G phosphorylation despite reducing mTOR signaling.

Authors:  Thomas C Vary; Gina Deiter; Stacy A Goodman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09-23       Impact factor: 4.733

5.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

Review 6.  Rapamycins: mechanism of action and cellular resistance.

Authors:  Shile Huang; Mary-Ann Bjornsti; Peter J Houghton
Journal:  Cancer Biol Ther       Date:  2003 May-Jun       Impact factor: 4.742

7.  Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.

Authors:  Julie R McMullen; Megan C Sherwood; Oleg Tarnavski; Li Zhang; Adam L Dorfman; Tetsuo Shioi; Seigo Izumo
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

8.  At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.

Authors:  Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2009-06-21       Impact factor: 4.534

9.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

Review 10.  Sirtuins in mammals: insights into their biological function.

Authors:  Shaday Michan; David Sinclair
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

View more
  5 in total

1.  High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.

Authors:  Paige Yellen; Mahesh Saqcena; Darin Salloum; Jiangnan Feng; Angela Preda; Limei Xu; Vanessa Rodrik-Outmezguine; David A Foster
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

2.  Rag GTPases and AMPK/TSC2/Rheb mediate the differential regulation of mTORC1 signaling in response to alcohol and leucine.

Authors:  Ly Q Hong-Brown; C Randell Brown; Abid A Kazi; Maithili Navaratnarajah; Charles H Lang
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-21       Impact factor: 4.249

3.  Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes.

Authors:  Ly Q Hong-Brown; C Randell Brown; Maithili Navaratnarajah; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2013-07-29       Impact factor: 3.455

Review 4.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

Review 5.  Alcohol consumption and hormonal alterations related to muscle hypertrophy: a review.

Authors:  Antonino Bianco; Ewan Thomas; Francesco Pomara; Garden Tabacchi; Bettina Karsten; Antonio Paoli; Antonio Palma
Journal:  Nutr Metab (Lond)       Date:  2014-06-06       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.